2023 Q4 Form 10-K Financial Statement
#000141057824000198 Filed on March 14, 2024
Income Statement
Concept | 2023 Q4 | 2023 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $1.385M | $6.071M |
YoY Change | -5.95% | -7.81% |
% of Gross Profit | ||
Research & Development | $832.4K | $3.308M |
YoY Change | 35.77% | 23.76% |
% of Gross Profit | ||
Depreciation & Amortization | $25.68K | $103.7K |
YoY Change | -1.27% | -0.32% |
% of Gross Profit | ||
Operating Expenses | $2.218M | $9.379M |
YoY Change | 6.32% | 1.3% |
Operating Profit | ||
YoY Change | ||
Interest Expense | $167.8K | $691.9K |
YoY Change | 97.47% | -212.14% |
% of Operating Profit | ||
Other Income/Expense, Net | $0.00 | $691.9K |
YoY Change | -658.95% | |
Pretax Income | -$2.050M | -$8.687M |
YoY Change | 2.44% | -7.41% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$2.050M | -$8.687M |
YoY Change | 2.44% | -7.41% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$3.19 | -$9.64 |
COMMON SHARES | ||
Basic Shares Outstanding | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q4 | 2023 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $10.69M | $10.69M |
YoY Change | -16.79% | -16.79% |
Cash & Equivalents | $2.400M | |
Short-Term Investments | $8.294M | $8.294M |
Other Short-Term Assets | $591.0K | $591.0K |
YoY Change | 14.41% | 14.41% |
Inventory | ||
Prepaid Expenses | $591.0K | |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $11.29M | $11.29M |
YoY Change | -15.59% | -15.59% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | $583.3K | |
YoY Change | -17.21% | |
Long-Term Investments | ||
YoY Change | ||
Other Assets | $300.0K | $300.0K |
YoY Change | -21.75% | -21.75% |
Total Long-Term Assets | $883.3K | $883.3K |
YoY Change | -18.81% | -18.81% |
TOTAL ASSETS | ||
Total Short-Term Assets | $11.29M | $11.29M |
Total Long-Term Assets | $883.3K | $883.3K |
Total Assets | $12.17M | $12.17M |
YoY Change | -15.83% | -15.83% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $526.5K | $526.5K |
YoY Change | -13.06% | -13.06% |
Accrued Expenses | $1.309M | $2.455M |
YoY Change | 11.31% | 5.73% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $600.0K | $600.0K |
YoY Change | 0.0% | 0.0% |
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $3.581M | $3.581M |
YoY Change | 1.53% | 1.53% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $2.924M | $2.924M |
YoY Change | -17.03% | -17.03% |
Other Long-Term Liabilities | $2.924M | |
YoY Change | -17.03% | |
Total Long-Term Liabilities | $2.924M | $2.924M |
YoY Change | -17.03% | -17.03% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $3.581M | $3.581M |
Total Long-Term Liabilities | $2.924M | $2.924M |
Total Liabilities | $6.505M | $6.505M |
YoY Change | -7.74% | -7.74% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$46.20M | |
YoY Change | 23.15% | |
Common Stock | $0.00 | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $5.664M | $5.664M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $12.17M | $12.17M |
YoY Change | -15.83% | -15.83% |
Cashflow Statement
Concept | 2023 Q4 | 2023 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$2.050M | -$8.687M |
YoY Change | 2.44% | -7.41% |
Depreciation, Depletion And Amortization | $25.68K | $103.7K |
YoY Change | -1.27% | -0.32% |
Cash From Operating Activities | -$3.224M | -$7.864M |
YoY Change | 65.97% | -7.27% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $2.644M | $2.188M |
YoY Change | -122.11% | |
Cash From Investing Activities | $2.644M | $2.188M |
YoY Change | -121.56% | |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -182.6K | 5.217M |
YoY Change | -59.14% | -62.76% |
NET CHANGE | ||
Cash From Operating Activities | -3.224M | -7.864M |
Cash From Investing Activities | 2.644M | 2.188M |
Cash From Financing Activities | -182.6K | 5.217M |
Net Change In Cash | -762.2K | -459.4K |
YoY Change | -68.1% | -90.06% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$3.224M | -$7.864M |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q4 | us-gaap |
Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/srt/2023#OfficerMember | |
CY2023Q4 | us-gaap |
Other Liability Noncurrent Related Party Type Extensible Enumeration
OtherLiabilityNoncurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/srt/2023#OfficerMember | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2023Q4 | us-gaap |
Other Liability Related Party Type Extensible Enumeration
OtherLiabilityRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/srt/2023#OfficerMember | |
CY2023Q4 | us-gaap |
Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/srt/2023#OfficerMember | |
CY2023Q4 | us-gaap |
Other Liability Noncurrent Related Party Type Extensible Enumeration
OtherLiabilityNoncurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/srt/2023#OfficerMember | |
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001671502 | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
Quoin Pharmaceuticals, Ltd. | |
CY2022Q4 | us-gaap |
Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/srt/2023#OfficerMember | |
CY2022Q4 | us-gaap |
Other Liability Noncurrent Related Party Type Extensible Enumeration
OtherLiabilityNoncurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/srt/2023#OfficerMember | |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
987220 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
403887 | |
CY2023Q3 | qnrx |
Shares Owned Percentage
SharesOwnedPercentage
|
0.00083 | |
CY2023Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
1.67 | |
CY2023 | us-gaap |
Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#ResearchAndDevelopmentExpense | |
CY2022Q4 | us-gaap |
Other Liability Related Party Type Extensible Enumeration
OtherLiabilityRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/srt/2023#OfficerMember | |
CY2022Q4 | us-gaap |
Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/srt/2023#OfficerMember | |
CY2022Q4 | us-gaap |
Other Liability Noncurrent Related Party Type Extensible Enumeration
OtherLiabilityNoncurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/srt/2023#OfficerMember | |
CY2023Q3 | qnrx |
Shares Owned Percentage
SharesOwnedPercentage
|
0.00083 | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
001-37846 | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
L3 | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
92-2593104 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
42127 Pleasant Forest Court | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Ashburn | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
VA | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
20148 | |
CY2023 | dei |
City Area Code
CityAreaCode
|
703 | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
980-4182 | |
CY2023 | dei |
Security12b Title
Security12bTitle
|
American Depositary Shares | |
CY2023 | dei |
Trading Symbol
TradingSymbol
|
QNRX | |
CY2023 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
5800000 | |
CY2023Q4 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2023Q4 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2023 | dei |
Auditor Name
AuditorName
|
Marcum LLP | |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
688 | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
East Hanover, New Jersey | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2401198 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2860628 | |
CY2023Q4 | us-gaap |
Investments
Investments
|
8293663 | |
CY2022Q4 | us-gaap |
Investments
Investments
|
9992900 | |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
591034 | |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
516584 | |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
11285895 | |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
13370112 | |
CY2023Q4 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
300000 | |
CY2022Q4 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
383390 | |
CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
583334 | |
CY2022Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
704561 | |
CY2023Q4 | us-gaap |
Assets
Assets
|
12169229 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
14458063 | |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
526523 | |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
605600 | |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1308706 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1175705 | |
CY2023Q4 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
1146251 | |
CY2022Q4 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
1146251 | |
CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
600000 | |
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
600000 | |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3581480 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3527556 | |
CY2023Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
2923733 | |
CY2022Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
3523733 | |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
6505213 | |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
7051289 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
8333334 | |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
987220 | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
403887 | |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
0 | |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
0 | |
CY2023 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
0 | |
CY2022 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
45 | |
CY2022Q4 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
2932000 | |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
51867336 | |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
47855521 | |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-46203320 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-37516747 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5664016 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
7406774 | |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
12169229 | |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
14458063 | |
CY2023 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
6070517 | |
CY2022 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
6584868 | |
CY2023 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3307987 | |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2672836 | |
CY2023 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
9378504 | |
CY2022 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
9257704 | |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
416000 | |
CY2022 | qnrx |
Warrant Liability Income Expense Value
WarrantLiabilityIncomeExpenseValue
|
-77237 | |
CY2023 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-2683 | |
CY2022 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
1307 | |
CY2023 | qnrx |
Realized And Accrued Interest Income
RealizedAndAccruedInterestIncome
|
694614 | |
CY2022 | qnrx |
Realized And Accrued Interest Income
RealizedAndAccruedInterestIncome
|
95745 | |
CY2022 | qnrx |
Increase In Accrued Interest And Financing Expenses
IncreaseInAccruedInterestAndFinancingExpenses
|
714081 | |
CY2023 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
691931 | |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-123792 | |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8686573 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9381496 | |
CY2022 | qnrx |
Deemed Dividend On Warrant Modification
DeemedDividendOnWarrantModification
|
65266 | |
CY2023 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-8686573 | |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-9446762 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
657032 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9381496 | |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
764007 | |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
14877332 | |
CY2022 | qnrx |
Stock Issued During Period Value Settlement Of Accrued Liabilities
StockIssuedDuringPeriodValueSettlementOfAccruedLiabilities
|
193537 | |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
296362 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
7406774 | |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8686573 | |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1094549 | |
CY2023 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
5849266 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5664016 | |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-8686573 | |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-9381496 | |
CY2022 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-77237 | |
CY2023 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1094549 | |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
764007 | |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
416000 | |
CY2023 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
103706 | |
CY2022 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
104043 | |
CY2023 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
17521 | |
CY2022 | qnrx |
Increase In Accrued Interest And Financing Expenses
IncreaseInAccruedInterestAndFinancingExpenses
|
714081 | |
CY2023 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
489079 | |
CY2022 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
93779 | |
CY2023 | qnrx |
Increase Decrease In Accounts Payable And Accrued Expenses
IncreaseDecreaseInAccountsPayableAndAccruedExpenses
|
53924 | |
CY2022 | qnrx |
Increase Decrease In Accounts Payable And Accrued Expenses
IncreaseDecreaseInAccountsPayableAndAccruedExpenses
|
-217806 | |
CY2023 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-41523 | |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-123455 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-7864429 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-8480732 | |
CY2023 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
18090684 | |
CY2022 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
9899121 | |
CY2023 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
20279000 | |
CY2022 | qnrx |
Payments For Previous Intangible Asset Acquisition
PaymentsForPreviousIntangibleAssetAcquisition
|
250000 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
2188316 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-10149121 | |
CY2023 | qnrx |
Payments For Proceeds From Deferred Loan Costs
PaymentsForProceedsFromDeferredLoanCosts
|
32583 | |
CY2022 | qnrx |
Payments For Proceeds From Deferred Loan Costs
PaymentsForProceedsFromDeferredLoanCosts
|
-42045 | |
CY2023 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
600000 | |
CY2022 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
599999 | |
CY2022 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
311670 | |
CY2023 | qnrx |
Net Proceeds From Issuance Of Common Stock
NetProceedsFromIssuanceOfCommonStock
|
5849266 | |
CY2022 | qnrx |
Net Proceeds From Issuance Of Common Stock
NetProceedsFromIssuanceOfCommonStock
|
14877332 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5216683 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
14007708 | |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-459430 | |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-4622145 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2860628 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7482773 | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2401198 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2860628 | |
CY2022 | qnrx |
Reclassification Of Warrant Liability To Equity Upon Issuance Of Exchange Warrants
ReclassificationOfWarrantLiabilityToEquityUponIssuanceOfExchangeWarrants
|
296362 | |
CY2022 | qnrx |
Deemed Dividend On Warrant Modification
DeemedDividendOnWarrantModification
|
65266 | |
CY2023 | qnrx |
Offering Expenses Associated With Warrant Modification
OfferingExpensesAssociatedWithWarrantModification
|
238231 | |
CY2022 | qnrx |
Offering Expenses Associated With Warrant Modification
OfferingExpensesAssociatedWithWarrantModification
|
491601 | |
CY2022 | qnrx |
Settlement Of Accrued Liabilities
SettlementOfAccruedLiabilities
|
193537 | |
CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
46200000 | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2400000 | |
CY2023Q4 | us-gaap |
Investments
Investments
|
8300000 | |
CY2023Q3 | qnrx |
Number Of Shares Represented For One American Depositary Share
NumberOfSharesRepresentedForOneAmericanDepositaryShare
|
60000 | |
CY2023Q4 | qnrx |
Number Of Ordinary Shares For American Depositary Shares
NumberOfOrdinarySharesForAmericanDepositaryShares
|
60000 | |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Use of estimates:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Actual results could materially differ from those estimates. Management considers many factors in developing the estimates and assumptions that are used in the preparation of these financial statements including: expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: settlement of debt or other obligations, stock-based compensation, research and development expense recognition, intangible asset estimated useful lives and impairment assessments, allowances of deferred tax assets, and cash flow assumptions regarding going concern considerations.</p> | |
CY2023Q4 | us-gaap |
Trading Securities
TradingSecurities
|
8300000 | |
CY2022Q4 | us-gaap |
Trading Securities
TradingSecurities
|
10000000.0 | |
CY2023 | qnrx |
Investmentsmaturityterm
Investmentsmaturityterm
|
P4M | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P10Y | |
CY2023 | us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
1 | |
CY2022 | us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
0 | |
CY2023Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
32583 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2023Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2023Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
401972 | |
CY2022Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
508084 | |
CY2023Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
8500 | |
CY2022Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
8500 | |
CY2021Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
12000000.0 | |
CY2022Q3 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
33333 | |
CY2022Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
491000 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.106 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.060 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.048 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.027 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.000 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.000 | |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y4M24D | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y10M24D | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
6.62 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
210.00 | |
CY2023 | qnrx |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value Of American Depositary Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValueOfAmericanDepositaryShare
|
4.31 | |
CY2022 | qnrx |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value Of American Depositary Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValueOfAmericanDepositaryShare
|
184.56 | |
CY2023 | qnrx |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Estimated Fair Value Of Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEstimatedFairValueOfOption
|
3.60 | |
CY2022 | qnrx |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Estimated Fair Value Of Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsEstimatedFairValueOfOption
|
155.04 | |
CY2023 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1090000.00 | |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
764000 | |
CY2023Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
3.0 | |
CY2023 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P3Y8M12D | |
CY2023Q4 | qnrx |
Prepaid Research And Development Costs
PrepaidResearchAndDevelopmentCosts
|
447979 | |
CY2022Q4 | qnrx |
Prepaid Research And Development Costs
PrepaidResearchAndDevelopmentCosts
|
383390 | |
CY2023Q4 | us-gaap |
Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
|
891034 | |
CY2022Q4 | us-gaap |
Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
|
899974 | |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
591034 | |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
516584 | |
CY2023Q4 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
300000 | |
CY2022Q4 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
383390 | |
CY2023Q4 | qnrx |
Accrued Research Contract Expense Current
AccruedResearchContractExpenseCurrent
|
358287 | |
CY2022Q4 | qnrx |
Accrued Research Contract Expense Current
AccruedResearchContractExpenseCurrent
|
105071 | |
CY2023Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
804156 | |
CY2022Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
788169 | |
CY2023Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
93989 | |
CY2022Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
159593 | |
CY2023Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
50534 | |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
44278 | |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1740 | |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
78594 | |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1308706 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1175705 | |
CY2022Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
3523733 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1000000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1040433 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
416666 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
335872 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
583334 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
704561 | |
CY2023 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
104000 | |
CY2022 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
104000 | |
CY2023 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
18000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
100000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
100000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
100000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
100000 | |
CY2023Q4 | qnrx |
Finite Lived Intangible Assets Amortization After Year Four
FiniteLivedIntangibleAssetsAmortizationAfterYearFour
|
183000 | |
CY2023Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
3523733 | |
CY2022Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
4123732 | |
CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
600000 | |
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
600000 | |
CY2023Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
2923733 | |
CY2022Q3 | qnrx |
Shares Owned Percentage
SharesOwnedPercentage
|
0.125 | |
CY2023Q4 | qnrx |
Number Of Ordinary Shares For American Depositary Shares
NumberOfOrdinarySharesForAmericanDepositaryShares
|
500000000000 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0 | |
CY2023Q4 | qnrx |
Number Of Ordinary Shares For American Depositary Shares
NumberOfOrdinarySharesForAmericanDepositaryShares
|
6000000000000 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
CY2023Q4 | us-gaap |
Treasury Stock Shares Retired
TreasuryStockSharesRetired
|
45 | |
CY2023Q4 | qnrx |
Number Of Years Income For Distribution Limit
NumberOfYearsIncomeForDistributionLimit
|
2 | |
CY2023 | qnrx |
Date Of Financial Statements And Distribution Period Maximum
DateOfFinancialStatementsAndDistributionPeriodMaximum
|
P6M | |
CY2023Q4 | qnrx |
Number Of Years Income For Distribution Limit
NumberOfYearsIncomeForDistributionLimit
|
2 | |
CY2022Q3 | qnrx |
Stock Issued During Period Shares Settlement Of Accrued Liabilities
StockIssuedDuringPeriodSharesSettlementOfAccruedLiabilities
|
3682 | |
CY2023Q1 | qnrx |
Aggregate Gross Proceeds From Issuance Offering
AggregateGrossProceedsFromIssuanceOffering
|
7000000.0 | |
CY2023Q1 | qnrx |
Net Proceeds From Issuance Offering
NetProceedsFromIssuanceOffering
|
5800000 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
664.68 | |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
597.00 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
64.20 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
16.13 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
4276000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3334000 | |
CY2023Q4 | qnrx |
Deferred Tax Assets Tax Deferred Expense Accrued Expenses And Other
DeferredTaxAssetsTaxDeferredExpenseAccruedExpensesAndOther
|
175000 | |
CY2022Q4 | qnrx |
Deferred Tax Assets Tax Deferred Expense Accrued Expenses And Other
DeferredTaxAssetsTaxDeferredExpenseAccruedExpensesAndOther
|
189000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
321000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
76000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
289000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
178000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
1104000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
581000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
51000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
34000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
6216000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
4392000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
6216000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
4392000 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2023 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-1824000 | |
CY2022 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-1970000 | |
CY2023 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
167000 | |
CY2022 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
153000 | |
CY2023 | qnrx |
Effective Income Tax Rate Reconciliation Research And Development Amount
EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentAmount
|
-195000 | |
CY2022 | qnrx |
Effective Income Tax Rate Reconciliation Research And Development Amount
EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentAmount
|
-76000 | |
CY2023 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
79000 | |
CY2022 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
388000 | |
CY2023 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
1824000 | |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
347000 | |
CY2023 | qnrx |
Effective Income Tax Rate Reconciliation Deferred True Up Amount
EffectiveIncomeTaxRateReconciliationDeferredTrueUpAmount
|
-51000 | |
CY2022 | qnrx |
Effective Income Tax Rate Reconciliation Deferred True Up Amount
EffectiveIncomeTaxRateReconciliationDeferredTrueUpAmount
|
1158000 | |
CY2023 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
6216000 | |
CY2022 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
4392000 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
CY2023 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
CY2023Q4 | qnrx |
Deferred Tax Asset Capitalization Of Research And Development Costs
DeferredTaxAssetCapitalizationOfResearchAndDevelopmentCosts
|
4617000 | |
CY2023 | us-gaap |
Loss Contingency Disclosures
LossContingencyDisclosures
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">NOTE 16 - CONTINGENCIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">From time to time, the Company may become involved in various legal matters arising in the ordinary course of business. Management is unaware of any matters requiring accrual for related losses in the financial statements.</p> | |
CY2023 | qnrx |
Number Of License And Supply Agreements Entered
NumberOfLicenseAndSupplyAgreementsEntered
|
9 | |
CY2022 | qnrx |
Number Of License And Supply Agreements Entered
NumberOfLicenseAndSupplyAgreementsEntered
|
8 | |
CY2023 | us-gaap |
Royalty Income Nonoperating
RoyaltyIncomeNonoperating
|
0 |